Literature DB >> 183962

Alterations in the efficacy of naloxone induced by stress, cyclic adenosine monophosphate, and morphine tolerance.

R A Harris, H H Loh, E L Way.   

Abstract

Pretreatment of mice with a single injection of morphine or by chronic implantation of morphine pellets increased the ability of naloxone to antagonize the analgetic effects of morphine. However, this increased effectiveness of naloxone was also produced by pretreatment with diethylether, ACTH, corticosterone or dexamethasone. Thus, the increased potency of naloxone observed after pretreatment with narcotics may be due, at least in part, to those pretreatments on the pituitary--adrenal axis. In addition, in animals made highly tolerant and dependent by cAMP administration during morphine pellet implantation, the narcotic antagonist potency of naloxone was similar to that of untreated animals.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 183962     DOI: 10.1016/0014-2999(76)90107-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  The effects of opiate receptor agonists and antagonists on the stress-induced secretion of corticosterone in mice.

Authors:  A Gibson; M Ginsburg; M Hall; S L Hart
Journal:  Br J Pharmacol       Date:  1979-01       Impact factor: 8.739

2.  Opiate binding and effect in ileum preparations from normal and morphine pretreated guinea-pigs.

Authors:  B M Cox; R Padhya
Journal:  Br J Pharmacol       Date:  1977-10       Impact factor: 8.739

3.  In vivo apparent pA2 analysis in rats treated with either clocinnamox or morphine.

Authors:  E A Walker; T M Richardson; A M Young
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

4.  Contractile effect of morphine and related opioid alkaloids, beta-endorphin and methionine enkephalin on the isolated colon from Long Evans rats.

Authors:  J P Huidobro-Toro; E L Way
Journal:  Br J Pharmacol       Date:  1981-11       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.